Teachers Retirement System of the State of Kentucky’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-17,400
Closed -$66K 1786
2020
Q1
$66K Hold
17,400
﹤0.01% 1622
2019
Q4
$89K Hold
17,400
﹤0.01% 1649
2019
Q3
$88K Hold
17,400
﹤0.01% 1651
2019
Q2
$107K Hold
17,400
﹤0.01% 1645
2019
Q1
$81K Hold
17,400
﹤0.01% 1683
2018
Q4
$73K Hold
17,400
﹤0.01% 1685
2018
Q3
$109K Hold
17,400
﹤0.01% 1696
2018
Q2
$140K Hold
17,400
﹤0.01% 1667
2018
Q1
$130K Sell
17,400
-6,600
-28% -$43.9K ﹤0.01% 1667
2017
Q4
$143K Hold
24,000
﹤0.01% 1652
2017
Q3
$177K Hold
24,000
﹤0.01% 1602
2017
Q2
$163K Hold
24,000
﹤0.01% 1614
2017
Q1
$227K Buy
+24,000
New +$240K ﹤0.01% 1551

Other funds holding PGNX

Teachers Retirement System of the State of Kentucky's PGNX Position: Q2 2020 in Review

Teachers Retirement System of the State of Kentucky sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 17,400 shares — an estimated $66K sold.

Teachers Retirement System of the State of Kentucky first reported a position in PGNX in Q1 2017 and held it in 13 quarters. The position peaked at $227K in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Teachers Retirement System of the State of Kentucky reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Teachers Retirement System of the State of Kentucky sold 17,400 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $66K.
  • Teachers Retirement System of the State of Kentucky first reported a position in Progenics Pharmaceuticals Inc in Q1 2017 and held it in 13 quarters.
  • Teachers Retirement System of the State of Kentucky's Progenics Pharmaceuticals Inc position peaked at $227K in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Teachers Retirement System of the State of Kentucky's 13F filing for Q2 2020, filed 4 Sep 2020.